Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.56
(-2.36%)
CNY 4.56
(-2.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -104.37 Million CNY | -1295.33% |
| 2022 | 14.46 Million CNY | 167.37% |
| 2021 | -21.47 Million CNY | 95.83% |
| 2020 | -514.47 Million CNY | 7.35% |
| 2019 | -555.28 Million CNY | -317.81% |
| 2018 | 254.93 Million CNY | -1.23% |
| 2017 | 258.1 Million CNY | -41.46% |
| 2016 | 440.91 Million CNY | 6.05% |
| 2015 | 415.75 Million CNY | 41.61% |
| 2014 | 293.59 Million CNY | 11837.04% |
| 2013 | 2.45 Million CNY | 103.97% |
| 2012 | -61.94 Million CNY | -12.23% |
| 2011 | -55.19 Million CNY | -129.89% |
| 2010 | -24.01 Million CNY | 89.59% |
| 2009 | -230.59 Million CNY | -558.96% |
| 2008 | -34.99 Million CNY | -3094.88% |
| 2007 | -1.09 Million CNY | -168.21% |
| 2006 | 1.6 Million CNY | -41.14% |
| 2005 | 2.72 Million CNY | 104.06% |
| 2004 | -67.17 Million CNY | -31.89% |
| 2003 | -50.92 Million CNY | -411.77% |
| 2002 | 16.33 Million CNY | 33.9% |
| 2001 | 12.2 Million CNY | -76.88% |
| 2000 | 52.75 Million CNY | -17.62% |
| 1999 | 64.03 Million CNY | 92.44% |
| 1998 | 33.27 Million CNY | 20.16% |
| 1997 | 27.69 Million CNY | 42.07% |
| 1996 | 19.49 Million CNY | 112.18% |
| 1995 | 9.18 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -24.74 Million CNY | -582.1% |
| 2024 Q1 | 5.13 Million CNY | 103.01% |
| 2024 Q3 | -3.28 Million CNY | 86.73% |
| 2023 Q2 | 3.66 Million CNY | -66.46% |
| 2023 Q4 | -170.71 Million CNY | -917.13% |
| 2023 Q1 | 10.92 Million CNY | 111.62% |
| 2023 FY | -172.91 Million CNY | -1295.33% |
| 2023 Q3 | -16.78 Million CNY | -558.04% |
| 2022 Q1 | 24.09 Million CNY | 113.78% |
| 2022 Q2 | 18.39 Million CNY | -23.65% |
| 2022 Q3 | -418.01 Thousand CNY | -102.27% |
| 2022 FY | 14.46 Million CNY | 167.37% |
| 2022 Q4 | -94.06 Million CNY | -22401.9% |
| 2021 Q3 | -54.8 Million CNY | -179.43% |
| 2021 Q4 | -174.89 Million CNY | -219.1% |
| 2021 FY | -21.47 Million CNY | 95.83% |
| 2021 Q1 | 24.8 Million CNY | 102.05% |
| 2021 Q2 | 69 Million CNY | 178.19% |
| 2020 Q3 | -72.91 Million CNY | -144.63% |
| 2020 FY | -514.47 Million CNY | 7.35% |
| 2020 Q1 | -1.66 Million CNY | 99.78% |
| 2020 Q2 | 163.35 Million CNY | 9911.81% |
| 2020 Q4 | -1.21 Billion CNY | -1562.83% |
| 2019 Q2 | 57.18 Million CNY | 337.16% |
| 2019 FY | -555.28 Million CNY | -317.81% |
| 2019 Q4 | -765.01 Million CNY | -258.08% |
| 2019 Q3 | -213.64 Million CNY | -473.6% |
| 2019 Q1 | 13.08 Million CNY | -87.65% |
| 2018 Q4 | 105.88 Million CNY | 135.56% |
| 2018 Q1 | 28.42 Million CNY | -61.87% |
| 2018 Q3 | 44.95 Million CNY | -40.6% |
| 2018 FY | 254.93 Million CNY | -1.23% |
| 2018 Q2 | 75.67 Million CNY | 166.21% |
| 2017 Q2 | 45.34 Million CNY | -11.12% |
| 2017 FY | 258.1 Million CNY | -41.46% |
| 2017 Q1 | 51.01 Million CNY | -78.68% |
| 2017 Q4 | 74.55 Million CNY | 0.57% |
| 2017 Q3 | 74.13 Million CNY | 63.48% |
| 2016 FY | 440.91 Million CNY | 6.05% |
| 2016 Q2 | 105.36 Million CNY | 194.67% |
| 2016 Q4 | 239.25 Million CNY | 295.17% |
| 2016 Q1 | 35.75 Million CNY | -82.43% |
| 2016 Q3 | 60.54 Million CNY | -42.54% |
| 2015 Q1 | 55.46 Million CNY | -82.2% |
| 2015 Q3 | 77.64 Million CNY | -1.85% |
| 2015 Q4 | 203.53 Million CNY | 162.14% |
| 2015 FY | 415.75 Million CNY | 41.61% |
| 2015 Q2 | 79.11 Million CNY | 42.62% |
| 2014 Q2 | -8.36 Million CNY | -18.26% |
| 2014 FY | 293.59 Million CNY | 11837.04% |
| 2014 Q4 | 311.67 Million CNY | 11917.98% |
| 2014 Q3 | -2.63 Million CNY | 68.49% |
| 2014 Q1 | -7.07 Million CNY | -156.35% |
| 2013 Q1 | -11.81 Million CNY | 64.15% |
| 2013 Q3 | 2.56 Million CNY | 402.73% |
| 2013 FY | 2.45 Million CNY | 103.97% |
| 2013 Q4 | 12.55 Million CNY | 389.0% |
| 2013 Q2 | -848.41 Thousand CNY | 92.82% |
| 2012 Q3 | -11.73 Million CNY | -75.88% |
| 2012 FY | -61.94 Million CNY | -12.23% |
| 2012 Q2 | -6.67 Million CNY | 36.83% |
| 2012 Q1 | -10.56 Million CNY | 52.06% |
| 2012 Q4 | -32.96 Million CNY | -180.84% |
| 2011 Q1 | -10.84 Million CNY | -708.05% |
| 2011 Q2 | -8.21 Million CNY | 24.29% |
| 2011 Q3 | -14.1 Million CNY | -71.75% |
| 2011 FY | -55.19 Million CNY | -129.89% |
| 2011 Q4 | -22.03 Million CNY | -56.28% |
| 2010 Q4 | 1.78 Million CNY | 118.87% |
| 2010 FY | -24.01 Million CNY | 89.59% |
| 2010 Q2 | -7.76 Million CNY | 9.49% |
| 2010 Q1 | -8.57 Million CNY | 95.47% |
| 2010 Q3 | -9.45 Million CNY | -21.72% |
| 2009 Q3 | -15.26 Million CNY | -25.17% |
| 2009 FY | -230.59 Million CNY | -558.96% |
| 2009 Q2 | -12.19 Million CNY | 12.07% |
| 2009 Q1 | -13.87 Million CNY | 68.85% |
| 2009 Q4 | -189.25 Million CNY | -1139.48% |
| 2008 FY | -34.99 Million CNY | -3094.88% |
| 2008 Q3 | 4.47 Million CNY | 40.84% |
| 2008 Q2 | 3.18 Million CNY | 68.88% |
| 2008 Q4 | -44.53 Million CNY | -1094.29% |
| 2008 Q1 | 1.88 Million CNY | 269.33% |
| 2007 Q3 | -108.43 Thousand CNY | 92.01% |
| 2007 Q1 | 1.48 Million CNY | 251.52% |
| 2007 Q4 | -1.11 Million CNY | -925.64% |
| 2007 FY | -1.09 Million CNY | -168.21% |
| 2007 Q2 | -1.35 Million CNY | -191.55% |
| 2006 Q4 | -978.25 Thousand CNY | -408.64% |
| 2006 Q2 | 997.75 Thousand CNY | -21.4% |
| 2006 Q1 | 1.26 Million CNY | 448.48% |
| 2006 FY | 1.6 Million CNY | -41.14% |
| 2006 Q3 | 316.95 Thousand CNY | -68.23% |
| 2005 Q2 | 738.55 Thousand CNY | 148.6% |
| 2005 Q3 | 2.05 Million CNY | 178.47% |
| 2005 FY | 2.72 Million CNY | 104.06% |
| 2005 Q4 | -364.25 Thousand CNY | -117.71% |
| 2005 Q1 | 297.09 Thousand CNY | 100.41% |
| 2004 Q3 | -3.79 Million CNY | -168.05% |
| 2004 Q1 | 3.04 Million CNY | 104.53% |
| 2004 Q2 | 5.57 Million CNY | 82.88% |
| 2004 Q4 | -71.99 Million CNY | -1798.11% |
| 2004 FY | -67.17 Million CNY | -31.89% |
| 2003 Q1 | 2.21 Million CNY | -26.31% |
| 2003 FY | -50.92 Million CNY | -411.77% |
| 2003 Q4 | -67.26 Million CNY | -1081.39% |
| 2003 Q3 | 6.85 Million CNY | -5.71% |
| 2003 Q2 | 7.26 Million CNY | 228.71% |
| 2002 Q1 | 1.76 Million CNY | 0.0% |
| 2002 FY | 16.33 Million CNY | 33.9% |
| 2002 Q4 | 3 Million CNY | -51.97% |
| 2002 Q3 | 6.24 Million CNY | 17.37% |
| 2002 Q2 | 5.32 Million CNY | 201.74% |
| 2001 FY | 12.2 Million CNY | -76.88% |
| 2000 FY | 52.75 Million CNY | -17.62% |
| 1999 FY | 64.03 Million CNY | 92.44% |
| 1998 FY | 33.27 Million CNY | 20.16% |
| 1997 FY | 27.69 Million CNY | 42.07% |
| 1996 FY | 19.49 Million CNY | 112.18% |
| 1995 FY | 9.18 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 825.98 Million CNY | 112.637% |
| Zhejiang Zhenyuan Share Co., Ltd. | 113.04 Million CNY | 192.338% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -141.05 Million CNY | 26.0% |
| Yifan Pharmaceutical Co., Ltd. | -882.71 Million CNY | 88.175% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 40.51 Million CNY | 357.629% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.65 Billion CNY | 102.856% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -56.7 Million CNY | -84.07% |
| Boai NKY Medical Holdings Ltd. | 585.23 Million CNY | 117.835% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 344.97 Million CNY | 130.257% |